Handelsbanken Fonder’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,300
Closed -$298K 1575
2022
Q3
$298K Hold
13,300
﹤0.01% 1254
2022
Q2
$330K Hold
13,300
﹤0.01% 1275
2022
Q1
$516K Sell
13,300
-1,900
-13% -$73.7K ﹤0.01% 1182
2021
Q4
$889K Hold
15,200
﹤0.01% 957
2021
Q3
$901K Hold
15,200
﹤0.01% 960
2021
Q2
$1.32M Buy
15,200
+1,800
+13% +$156K 0.01% 780
2021
Q1
$1.11M Hold
13,400
0.01% 793
2020
Q4
$1.22M Hold
13,400
0.01% 746
2020
Q3
$536K Buy
13,400
+2,900
+28% +$116K ﹤0.01% 960
2020
Q2
$360K Buy
+10,500
New +$360K ﹤0.01% 1121